NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/20/2026
Back to search
Official data from USPTO
PHARMA CAPITAL PARTNERS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMA CAPITAL PARTNERS
ST13
US500000099171160Class
36
Filing
99171160
Registration
8112422
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
01/20/2026
Trademark type
Word
Nice classes
36
Filing date
05/06/2025
Registration date
01/20/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/20/2026
Last transaction
01/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
01/01/2008
First use in commerce
01/01/2008
Drawing code
4
Owner type
01
Owner location
Castro Valley, CA, US
Examiner
PEREZ, STEVEN M
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
R. J. (pessoa física)
Representatives
Radomir Julina
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Private equity fund investment services; Financial investment in the field of biopharmaceutical and life sciences companies; Financial planning and investment advisory services
Publications
History of USPTO decisions and trademark events.
13 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/20/2026
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/06/2025
GNRT
NON-FINAL ACTION E-MAILED
10/06/2025
CNRT
NON-FINAL ACTION WRITTEN
10/06/2025
DOCK
ASSIGNED TO EXAMINER
09/23/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/06/2025
NWAP
NEW APPLICATION ENTERED
05/06/2025
Continuous trademark protection
Get notified about every new filing that threatens PHARMA CAPITAL PARTNERS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.